Reportlinker finds all market research
reports published by official sources!
Company Report: Immunotherapy in France for Year 2012
- This 2-page company report was published in June 2012.
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
Therapy Industry in France : Latest Downloads
Company Report: Immunotherapy in France for Year 2012
- Company report
- June 2012
- 2 pages
... Such as severe rhinoconjunctivitis and rhinitis, as well as allergic asthma. The seventh largest pharmaceutical company in france and the leader in sublingual immunotherapy treatment, stallergenes devotes almost ...
Company Report: Hydrotherapy for Year 2013
- Company report
- March 2013
- 44 pages
... To develop ideas and evaluate options for the provision of water based exercise and hydrotherapy as a rehabilitation treatment modality across the scottish borders and to seek approval to move forward ...
Company Report: Therapy for Year 2012
- Company report
- November 2012
- 40 pages
... Whether caused by brain injury like cerebral palsy, a genetic condition like down S syndrome, autism, or general developmental delay, by the provision and promotion of therapy. Since 1982, brainwave has ...
Company Report: Therapy For Year 2012
7 months agoCompany Report: Therapy For Year 2012
7 months agoCompany Report: Therapy For Year 2012
12 months agoCompany Report: Chemotherapy For Year 2012
12 months agoMore Reports:
Therapy in the United States (7)
Related Market Segments :
Immunotherapy
Therapy Industry in France : Latest Reports
World Pharmaceutical: Stallergenes S.A. ? Product Pipeline Review - H2 2011
- $ 1 500
- Company report
- August 2012
- by Global Markets Direct
. - Product Pipeline Review - H2 2011? provides a detailed overview on the Stallergenes S.A.?s research and development focus. The report includes information on current developmental pipeline, complete ...
World Drug and Medication: Osteosarcoma - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Osteosarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
Lorus Therapeutics Inc. (LOR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- $ 250
- Company report
- March 2013
- by Global Data
Summary Lorus Therapeutics Inc. (Lorus) is a biopharmaceutical company with focus on the discovery, research and development of anticancer therapies. It focuses in the development of treatments for several ...
More Reports:
Therapy in Canada (24)
Therapy in France (42)
Therapy in Germany (45)
Therapy in Italy (44)
Therapy in Japan (53)
Therapy in Spain (43)
Related Market Segments :
Immunotherapy
Reportlinker.com © Copyright 2013. All rights reserved.
